COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,831 Articles (22,553 medRxiv, 8,278 bioRxiv)

Most recent first Previous |  Page 569: Articles 5681-5690  | Next

Risk factors for household transmission of SARS-Cov-2: a modelling study in the French national population-based EpiCov cohort
Novelli, S., Opatowski, L., Manto, C., Rahib, D., de Lamballerie, X., Warszawski, J., Meyer, L.
10.1101/2022.10.06.22280739 — Posted: 2022-10-07
Changes in Fentanyl Distribution in California
Dugan, M. V., Shah, A. H., Anthony, T. R., Famosa, R., Piper, B. J.
10.1101/2022.10.06.22280803 — Posted: 2022-10-07
Disparities in Naltrexone Prescriptions to Medicaid Enrollees During the COVID-19 Pandemic
Subervi, H. A., Varghese, L. E., Piper, B. J.
10.1101/2022.10.05.22280706 — Posted: 2022-10-07
Barriers to accessing mother, new-born and child health services in urban Gambia during COVID-19: An interview-based qualitative study.
Bah, A., Russo, G.
10.1101/2022.10.06.22280770 — Posted: 2022-10-07
SARS-CoV-2 infection alkalinizes the ERGIC and lysosomes through the viroporin activity of the viral envelope protein
Want, W.-A., Carreras Sureda, A., Demaurex, N.
10.1101/2022.10.04.510830 — Posted: 2022-10-06
Design and Immunogenicity of SARS-CoV-2 DNA vaccine encoding RBD-PVXCP fusion protein
Dormeshkin, D., Katsin, M., Stegantseva, M., Golenchenko, S., Shapira, M., Dubovik, S., Lutskovich, D., Kavaleuski, A., Meleshko, A.
10.1101/2022.10.06.511104 — Posted: 2022-10-06
Is The Stalk of the SARS-CoV-2 Spike Protein Druggable?
Pipito, L., Reynolds, C. A., Deganutti, G.
10.1101/2022.10.06.511069 — Posted: 2022-10-06
Characterizing Aerosol Generating Procedures with Background Oriented Schlieren
Howard, N. S., Alrefaie, A., Mejia, N. A., Ugbeye, T., Schmidt, B. E.
10.1101/2022.10.05.511018 — Posted: 2022-10-06
Long-term passaging of replication competent pseudo-typed SARS-CoV-2 reveals the antiviral breadth of monoclonal and bispecific antibody cocktails
Zhu, J., Ma, H., Zong, H., Liu, J., Yue, Y., Ke, Y., Liao, Y., Tang, H., Wang, L., Wang, S., Yuan, Y., Wu, M., Bian, Y., Zhang, B., Yin, H., Jiang, H., Sun, T., Han, L., Xie, Y.
10.1101/2022.10.05.511057 — Posted: 2022-10-06
Evaluation of the Abbott PanbioTM COVID-19 antigen detection rapid diagnostic test among healthcare workers in elderly care
Eikelenboom-Boskamp, A., den Ouden, M., de Groot, T., Stobernack, T., Wertheim, H., Voss, A.
10.1101/2022.10.04.22280700 — Posted: 2022-10-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).